Drreddys Laboratories | RDY - Gross Profit On Sales


Drreddys Laboratories reported INR46.81B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
ANI Pharmaceuticals USD 124.18M 12.39M Dec/2025
Aurora Cannabis CAD 46.62M 14.33M Dec/2025
Bayer EUR 6.94B 1.58B Dec/2025
Canopy Growth CAD 21.47M 434K Dec/2025
Cipla INR 41.64B 6.31B Dec/2025
Corcept Therapeutics USD 162.02M 37.56M Mar/2026
Drreddys Laboratories INR 46.81B 10.24B Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Novartis USD 10.07B 184M Mar/2026
Pacira USD 126.64M 15.61M Mar/2026
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Prestige Brands USD 157.37M 5.79M Dec/2025
Richter Gedeon HUF 143.37B 25.78B Sep/2025
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
Supernus Pharmaceuticals USD 129.36M 34.68M Mar/2026
Teva Pharmaceutical Industries USD 2.11B 547M Mar/2026